The Brainstem Noradrenergic Systems in Stress, Anxiety and Depression

被引:153
作者
Itoi, K. [1 ,2 ]
Sugimoto, N. [1 ]
机构
[1] Tohoku Univ, Grad Sch Informat Sci, Lab Informat Biol, Sendai, Miyagi 9808579, Japan
[2] Tohoku Univ, Grad Sch Med, Div Neuroendocrinol, Sendai, Miyagi 9808579, Japan
关键词
locus coeruleus; nucleus of the solitary tract; 6-hydroxydopamine; DSP-4; dopamine-beta hydroxylase; depression; CORTICOTROPIN-RELEASING HORMONE; LOCUS-CERULEUS NEURONS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYDROXYLASE GENE-EXPRESSION; MEDIAL PREFRONTAL CORTEX; SINGLE UNIT-ACTIVITY; FREELY MOVING CAT; TYROSINE-HYDROXYLASE; RAT-BRAIN; NEUROENDOCRINE RESPONSES;
D O I
10.1111/j.1365-2826.2010.01988.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The locus coeruleus (LC) is regarded as a part of the central 'stress circuitry' because robust activation of the LC has been reported after stressful stimuli in experimental animals. A considerable amount of clinical evidence also suggests the relationship between the central noradrenergic (NAergic) system and fear/anxiety states or depression. However, previous animal studies have not been able to demonstrate unequivocally the involvement of the NAergic system in mediating fear or anxiety. The forebrain structures, including the hypothalamus, receive massive inputs from the medullary NAergic nuclei via the ventral NAergic bundle (VNAB). The VNAB has been implicated in the neuroendocrine stress axis mainly through its action on the corticotrophin-releasing factor neurones in the paraventricular nucleus of the hypothalamus. Novel tools were introduced that are capable of disrupting the NAergic system more selectively and/or thoroughly than the neurotoxins employed in previous studies: the anti-dopamine-beta hydroxylase (DBH)-saporin is an immunotoxin that is taken up from nerve endings and disrupt the NAergic neurones in a retrograde manner. The genetically DBH-depleted mice were also introduced, which lack endogenous noradrenaline. Owing to the rapid development of functional imaging technique, visualisation of the emotional phenomena has become possible in human subjects. Along with the advent of these technologies, endeavors have been continued to unravel the functional relevance of the central NAergic system to stress, anxiety and depression.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 65 条
[1]  
Baldessarini R.J., 2006, Goodman Gilman's The Pharmacological Basis of Therapeutics, P429
[2]   The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes [J].
Berridge, CW ;
Waterhouse, BD .
BRAIN RESEARCH REVIEWS, 2003, 42 (01) :33-84
[3]   Gene regulation in the magnocellular hypothalamo-neurohypophysial system [J].
Burbach, JPH ;
Luckman, SM ;
Murphy, D ;
Gainer, H .
PHYSIOLOGICAL REVIEWS, 2001, 81 (03) :1197-1267
[4]   Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress [J].
Cecchi, M ;
Khoshbouei, H ;
Javors, M ;
Morilak, DA .
NEUROSCIENCE, 2002, 112 (01) :13-21
[5]   Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress [J].
Chang, MS ;
Sved, AF ;
Zigmond, MJ ;
Austin, MC .
NEUROSCIENCE, 2000, 101 (01) :131-139
[6]   Neuroanatomical circuits modulating fear and anxiety behaviors [J].
Charney, DS .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 :38-50
[7]   Locus coeruleus activation by foot shock or electrical stimulation inhibits amygdala neurons [J].
Chen, F. -J. ;
Sara, S. J. .
NEUROSCIENCE, 2007, 144 (02) :472-481
[8]   Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors [J].
Cryan, JF ;
O'Leary, OF ;
Jin, SH ;
Friedland, JC ;
Ouyang, M ;
Hirsch, BR ;
Page, ME ;
Dalvi, A ;
Thomas, SA ;
Lucki, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) :8186-8191
[9]   Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test [J].
Cryan, JF ;
Page, ME ;
Lucki, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (03) :197-205
[10]  
Cryan JF, 2001, J PHARMACOL EXP THER, V298, P651